PainRelief.com Interview with:

Sarah Stith PhD
Assistant Professor of Economics
University of New Mexico

PainRelief.com: What is the background for this study?

Response: We studied how the stock market returns of publicly traded pharmaceutical firms responded to medical and recreational cannabis legalization events. Our results show that stock market returns were 1.5-2% lower at 10 days following a single cannabis legalization event and that the annual sales implications from this reduction were in the billions.